Cargando…
Potent Activity of the HIV-1 Maturation Inhibitor Bevirimat in SCID-hu Thy/Liv Mice
BACKGROUND: The HIV-1 maturation inhibitor, 3-O-(3′,3′-dimethylsuccinyl) betulinic acid (bevirimat, PA-457) is a promising drug candidate with 10 nM in vitro antiviral activity against multiple wild-type (WT) and drug-resistant HIV-1 isolates. Bevirimat has a novel mechanism of action, specifically...
Autores principales: | Stoddart, Cheryl A., Joshi, Pheroze, Sloan, Barbara, Bare, Jennifer C., Smith, Philip C., Allaway, Graham P., Wild, Carl T., Martin, David E. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2080775/ https://www.ncbi.nlm.nih.gov/pubmed/18043758 http://dx.doi.org/10.1371/journal.pone.0001251 |
Ejemplares similares
-
Validation of the SCID-hu Thy/Liv Mouse Model with Four Classes of Licensed Antiretrovirals
por: Stoddart, Cheryl A., et al.
Publicado: (2007) -
Experimental Transmission of Kaposi's Sarcoma–Associated Herpesvirus (Kshv/Hhv-8) to Scid-Hu Thy/Liv Mice
por: Dittmer, D., et al.
Publicado: (1999) -
Human Herpesvirus 6 (HHV-6) Causes Severe Thymocyte Depletion in SCID-hu Thy/Liv Mice
por: Gobbi, Alberto, et al.
Publicado: (1999) -
Development of Bevirimat (PA-457): first-in-class HIV maturation inhibitor
por: Allaway, Graham P
Publicado: (2006) -
Albumin-conjugated C34 Peptide HIV-1 Fusion Inhibitor: EQUIPOTENT TO
C34 AND T-20 IN VITRO WITH SUSTAINED ACTIVITY IN SCID-HU THY/LIV
MICE
por: Stoddart, Cheryl A., et al.
Publicado: (2008)